376 related articles for article (PubMed ID: 9747065)
1. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation.
Perng RP; Hsieh WC; Chen YM; Lu CC; Chiang SJ
J Formos Med Assoc; 1998 Aug; 97(8):547-51. PubMed ID: 9747065
[TBL] [Abstract][Full Text] [Related]
2. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
Yudkin PL; Jones L; Lancaster T; Fowler GH
Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
[TBL] [Abstract][Full Text] [Related]
3. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers.
Ferguson SG; Gitchell JG; Shiffman S; Sembower MA
Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485
[TBL] [Abstract][Full Text] [Related]
4. Varying nicotine patch dose and type of smoking cessation counseling.
Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
[TBL] [Abstract][Full Text] [Related]
5. Predicting smoking cessation. Who will quit with and without the nicotine patch.
Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
[TBL] [Abstract][Full Text] [Related]
6. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
[TBL] [Abstract][Full Text] [Related]
7. [A double-blind trial of nicotine patches in smoking cessation].
Tønnesen P; Nørregaard J; Simonsen K; Säwe U
Ugeskr Laeger; 1992 Jan; 154(5):251-4. PubMed ID: 1736456
[TBL] [Abstract][Full Text] [Related]
8. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
[TBL] [Abstract][Full Text] [Related]
9. [Effects of transdermal nicotine as an adjunct in smoking cessation therapy. A double-blind randomized study controlled with placebo].
Daughton DM; Heatley SA; Prendergast JJ; Causey D; Knowles M; Rolf CN; Cheney RA; Hatlelid K; Thompson AB; De Blasio F
Arch Monaldi Mal Torace; 1992; 47(1-6):17-29. PubMed ID: 1306633
[TBL] [Abstract][Full Text] [Related]
10. Effect of pre-treatment with nicotine patch on withdrawal symptoms and abstinence rates in smokers subsequently quitting with the nicotine patch: a randomized controlled trial.
Schuurmans MM; Diacon AH; van Biljon X; Bolliger CT
Addiction; 2004 May; 99(5):634-40. PubMed ID: 15078238
[TBL] [Abstract][Full Text] [Related]
11. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
[TBL] [Abstract][Full Text] [Related]
12. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial.
Kornitzer M; Boutsen M; Dramaix M; Thijs J; Gustavsson G
Prev Med; 1995 Jan; 24(1):41-7. PubMed ID: 7740014
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
[TBL] [Abstract][Full Text] [Related]
14. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice.
Stapleton JA; Russell MA; Feyerabend C; Wiseman SM; Gustavsson G; Sawe U; Wiseman D
Addiction; 1995 Jan; 90(1):31-42. PubMed ID: 7888977
[TBL] [Abstract][Full Text] [Related]
15. Sociodemographic and smoking behavioral predictors associated with smoking cessation according to follow-up periods: a randomized, double-blind, placebo-controlled trial of transdermal nicotine patches.
Myung SK; Seo HG; Park S; Kim Y; Kim DJ; Lee DH; Seong MW; Nam MH; Oh SW; Kim JA; Kim MY
J Korean Med Sci; 2007 Dec; 22(6):1065-70. PubMed ID: 18162724
[TBL] [Abstract][Full Text] [Related]
16. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain.
Rigotti NA; Gonzales D; Dale LC; Lawrence D; Chang Y;
Addiction; 2009 Feb; 104(2):266-76. PubMed ID: 19149823
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation.
Davidson M; Epstein M; Burt R; Schaefer C; Whitworth G; McDonald A
Arch Fam Med; 1998; 7(6):569-74. PubMed ID: 9821833
[TBL] [Abstract][Full Text] [Related]
19. The transdermal nicotine patch: results of a randomised placebo-controlled trial.
Richmond RL; Harris K; de Almeida Neto A
Med J Aust; 1994 Jul; 161(2):130-5. PubMed ID: 8028537
[TBL] [Abstract][Full Text] [Related]
20. Targeting heavy smokers in general practice: randomised controlled trial of transdermal nicotine patches.
Russell MA; Stapleton JA; Feyerabend C; Wiseman SM; Gustavsson G; Sawe U; Connor P
BMJ; 1993 May; 306(6888):1308-12. PubMed ID: 8518572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
